News Chan Zuckerberg Initiative to put $250M into new NYC Biohub The Chan Zuckerberg Initiative's new NYC Biohub will develop new bio-engineered immune cells that can aide in early detection of diseases.
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.